Mimedx (MDXG) Other Non-Current Assets (2010 - 2026)

Mimedx (MDXG) reported Other Non-Current Assets of $6.9 million for Q1 2026, up 557.06% on a YoY basis from $1.0 million in Q1 2025, and down 5.33% sequentially from $7.3 million in Q4 2025.

Mimedx (MDXG) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Mimedx (MDXG) has 16 years of Other Non-Current Assets data on file, last reported at $6.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets rose 557.06% year-over-year to $6.9 million; the trailing twelve-month figure through Mar 2026 stood at $6.9 million (up 557.06% YoY), and the FY2025 full-year result was $7.3 million, up 8.37% from the prior year.
  • Other Non-Current Assets retreated to $6.9 million in Q1 2026, from $7.3 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $7.3 million in Q4 2025 to a low of $146000.0 in Q2 2023.
  • A 5-year average of $1.9 million and a median of $1.0 million in 2025 frame the typical range for Other Non-Current Assets.
  • Across the five-year window, Other Non-Current Assets plunged 84.6% in 2023 and soared 3174.15% in 2024, its largest moves.
  • Tracing MDXG's Other Non-Current Assets over 5 years: stood at $1.3 million in 2022, then sank by 84.6% to $205000.0 in 2023, then soared by 3174.15% to $6.7 million in 2024, then advanced by 8.37% to $7.3 million in 2025, then dropped by 5.33% to $6.9 million in 2026.
  • Business Quant data shows MDXG's Other Non-Current Assets at $6.9 million in Q1 2026, $7.3 million in Q4 2025, and $3.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Mimedx 615.09 Mn 455.31 Mn 41.62 Mn 6.89 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.89 Mn
Dec 31, 2025 7.27 Mn
Sep 30, 2025 2.99 Mn
Jun 30, 2025 990,000.00
Mar 31, 2025 1.05 Mn
Dec 31, 2024 6.71 Mn
Sep 30, 2024 1.18 Mn
Jun 30, 2024 1.24 Mn
Mar 31, 2024 1.25 Mn
Dec 31, 2023 205,000.00
Sep 30, 2023 149,000.00
Jun 30, 2023 146,000.00
Mar 31, 2023 147,000.00
Dec 31, 2022 1.33 Mn
Sep 30, 2022 150,000.00
Jun 30, 2022 164,000.00
Mar 31, 2022 172,000.00
Dec 31, 2021 186,000.00
Sep 30, 2021 270,000.00
Jun 30, 2021 313,000.00